lifitegrast is indicated for the treatment of which conditions
Xiidra (lifitegrast ophthalmic solution) 5%, for topical ophthalmic use is a lymphocyte function-associated antigen-1 (LFA-1) antagonist indicated for the treatment of the signs and symptoms of dry eye disease (DED). Common side effects of Xiidra include: 1  eye irritation or discomfort.  changes in taste, and.